Calyx Bio-Venture Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
49.30
105.40
128.40
Cost of Goods Sold (COGS) incl. D&A
-
13.40
128.90
306.00
196.70
Gross Income
-
13.40
79.60
200.60
68.30
SG&A Expense
1,465.00
554.90
370.80
494.30
1,382.50
EBIT
1,465.00
568.30
450.50
694.80
1,450.70
Unusual Expense
162.30
42.50
300.20
-
1.40
Non Operating Income/Expense
3.60
1.30
1.60
0.10
8.50
Interest Expense
-
-
-
1.40
8.70
Pretax Income
1,631.00
527.00
151.80
696.30
1,452.30
Equity in Affiliates
1,909.70
-
-
-
-
Consolidated Net Income
3,540.70
527.00
151.80
696.30
1,452.30
Net Income
3,540.70
527.00
151.80
696.30
1,452.30
Net Income After Extraordinaries
3,540.70
527.00
151.80
696.30
1,452.30
Net Income Available to Common
3,540.70
527.00
151.80
696.30
1,452.30
EPS (Basic)
0.11
0.01
0.00
0.01
0.02
Basic Shares Outstanding
33,328.50
38,954.60
48,760.70
52,473.80
63,294.50
EPS (Diluted)
0.11
0.01
0.00
0.01
0.02
Diluted Shares Outstanding
33,328.50
38,954.60
48,760.70
52,473.80
63,294.50
EBITDA
1,465.00
554.90
337.80
556.50
1,306.90
About Calyx Bio-Venture
View Profile
